Janus kinases (JAKs): The efficient therapeutic targets for autoimmune diseases and myeloproliferative disorders

Published 2020 View Full Article

  1. Home
  2. Publications
  3. Publication Search
  4. Publication Details
Title
Janus kinases (JAKs): The efficient therapeutic targets for autoimmune diseases and myeloproliferative disorders
Authors
Keywords
Autoimmune diseases, JAKs inhibitors, Rheumatoid arthritis (RA), SAR, Medicinal chemistry
Journal
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
Volume 192, Issue -, Pages 112155
Publisher
Elsevier BV
Online
2020-02-19
DOI
10.1016/j.ejmech.2020.112155

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation
Webinars Posters Questions Hubs Funding Journals Articles Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.